
Academic Journal
Q1Journal of Molecular Pathology
About Journal of Molecular Pathology
Journal of Molecular Pathology is a scholarly journal published by Multidisciplinary Digital Publishing Institute (MDPI). SCImago 2025 lists it in Q1, with an SJR of 0.578 and H-index of 11.
Coverage: 2020-2025. Research categories: Health Professions (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2).
Verified field sources
- Journal Impact Factor: 2.5 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from the publisher imprint.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from the publisher imprint.
- Editor(s): Prof. Dr. Giancarlo Troncone (Editor-in-Chief) — Official source; checked 2026-10-03. Editor-in-Chief listed on the journal homepage.
- Contact email: jmp@mdpi.com — Official source; checked 2026-10-03. Journal editorial office email published by MDPI; manuscript files use the submission system.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2023-04-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Cancer Genomics and Diagnostics; Lung Cancer Treatments and Mutations; Genetic factors in colorectal cancer; Molecular Biology Techniques and Applications; Cancer Cells and Metastasis; Lung Cancer Research Studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Gene and Isoform Misassignment Among Candidate TP53 and CDKN2A Variants of Uncertain Significance in Oral Squamous Cell Carcinoma: A Public-Database Curation Study
Spoorthi Ravi Banavar, Prashanthi Chippagiri, Suan Phaik Khoo
2026-09-22 · DOI: 10.3390/jmp7040035Molecular Pathology Insights into ALS Susceptibility: Exploratory Association of CYP46A1 rs754203 in Brazilian Case–Control Study
Angela Adamski da Silva Reis, Caroline Christine Pincela da Costa, Diolina Gonçalves da Silva, Nayane Soares de Lima et al.
2026-09-17 · DOI: 10.3390/jmp7030034Pathophysiology of Geographic Atrophy: RPE or Choroid as the Primary Culprit?
Victor Chong
2026-09-16 · DOI: 10.3390/jmp7030033Regulatory RNA Properties and Diagnostic Performance of the Non-Coding Transcript ENST00000453316 Across Solid Tumors
Tamara Babic, Sandra Dragicevic, Aleksandra Nikolic
2026-09-09 · DOI: 10.3390/jmp7030032Discrepancies in the Molecular Epidemiology of Druggable Genetic Alterations in Non-Small Cell Lung Cancer
Panagiotis Paliogiannis, Angelo Zinellu, Giuseppe Palmieri, Alessandro Giuseppe Fois et al.
2026-08-27 · DOI: 10.3390/jmp7030031Diagnostic Performance of Initial Bone Marrow Assessment in Cytopenia: Comparison with a Genetically Informed Multidisciplinary Tumour Board Diagnosis
Bernhard Strasser, Rita Steindl, Johann Mandl, Sebastian Mustafa et al.
2026-08-25 · DOI: 10.3390/jmp7030030Optimization of Focused Ultrasound-Mediated Blood–Brain Barrier Opening for CNS Therapeutic Delivery: Mechanistic Insights, Technical Parameters, and Clinical Translation
Mohammad Rashad, Agastya Mittal, Srivardhan Chirasani, Jerick Kim et al.
2026-08-18 · DOI: 10.3390/jmp7030029Clinicopathologic Spectrum of Renal Disease in SARS-CoV-2 Infection and Post-COVID-19 Vaccination
Naya Williams, Mohammed S. Razzaque
2026-07-29 · DOI: 10.3390/jmp7030028High Expression of PgRMC1 Correlates with Poor Neoadjuvant Chemotherapy Response and Alters Chemosensitivity in Breast Cancer Cells
Manami Tada, Tomohiro Chiba, Yoshiharu Ishizaka, Kaisuke Miyamoto et al.
2026-07-27 · DOI: 10.3390/jmp7030027Cytoplasmic Claudin 6 Expression and Copy Number Variations as a Prognosticator of Survival and Relapse in Ovarian Cancer Patients
Mourad Assidi, Sahar Hakamy, Mohammad A. Jafri, Fatima Al-Thubaity et al.
2026-07-08 · DOI: 10.3390/jmp7030026Metformin as an Upstream Substrate-Modifying Strategy for Atrial Fibrillation in Metabolic Dysfunction: Mechanistic Rationale and Clinical Evidence
Roopeessh Vempati, Christian Toquica Gahona, Fadi Haddad, Hari Vorappan Manickavelan et al.
2026-07-01 · DOI: 10.3390/jmp7030025Comparative Cytotoxicity and Inflammatory Profiles of CeraSeal Versus AH Plus in Periodontal Tissue Repair: An In Vitro and In Vivo Study
Gulnihol Sharipova, Jasur Rizaev, Shuxrat Boymuradov, Mirzaakbar Kamolov et al.
2026-06-15 · DOI: 10.3390/jmp7020024Pathomorphological Features of Diabetic Myopathy in Comorbid Conditions
Oksana Zhurakivska, Aleksandra Natalia Gabren-Syller, Oleh Koshkin, Viktor Mazurenko et al.
2026-06-05 · DOI: 10.3390/jmp7020023ATM Immunohistochemistry as a Tool to Identify and Classify Somatic ATM Variants in Prostate Cancer
Roger Ferreira, Kassandra R. Bisson, Andrea Beharry, Champica Nicholas et al.
2026-06-04 · DOI: 10.3390/jmp7020022Correction: Vernygorodskyi et al. Cancer-Associated Fibroblasts and Epithelial–Mesenchymal Transition as Critical Contributors to Renal Cell Carcinoma Progression. J. Mol. Pathol. 2025, 6, 31
Sergii Vernygorodskyi, Anton B. Tonchev, Nikolai T. Evtimov, Kameliya Zhechkova Bratoeva et al.
2026-05-30 · DOI: 10.3390/jmp7020021Understanding of Microbial Causes, Clinicopathological Evaluation, Molecular Analysis, and Associated Risk Factors of Ear Infections in Dogs
Gopakrishna Mohanty, Prasana Kumar Rath, Bidyut Prava Mishra, Annushree Mishra et al.
2026-05-19 · DOI: 10.3390/jmp7020020Analytical Validation of Quantitative Polymerase Chain Reaction and AscentTM Low-Pass Whole Genome Sequencing to Report on Gene Copy Number Variants in Cerebrospinal Fluid Tumor-Derived DNA
Viriya Keo, Sakshi Khurana, Vindhya Udhane, Alexandra Larson et al.
2026-05-12 · DOI: 10.3390/jmp7020018The Tight Connection Between the Gut Microbiota and Childhood Acute Lymphoblastic Leukaemia: An Updated Review
Marta Arrabito, Giulio Pulvirenti, Maria Santagati, Stefania Stefani et al.
2026-05-12 · DOI: 10.3390/jmp7020019A Narrative Approach to Mismatch Repair-Deficient Endometrial Cancer
Massimo Barberis, Yinxiu Zhan
2026-04-15 · DOI: 10.3390/jmp7020017Pediatric Ciliopathy Linked to TULP3 Variant—A Case Report
Mrunmayi Prashant Marathe, Snehavardhan Pandey, Anusha Kulkarni, Thenral S. Geetha et al.
2026-04-14 · DOI: 10.3390/jmp7020016Reviews
Community Reviews
Version History
October 2, 2026 at 9:17 pm
October 2, 2026